A clinical trial to compare the effects of coded Unani research drugs UNIM 001+UNIM003 with Psoralen in the treatment of vitiligo
- Conditions
- Health Condition 1: null- VITILIGOHealth Condition 2: L80- Vitiligo
- Registration Number
- CTRI/2013/12/004215
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 532
1.Patients with clinically diagnosed dermatomal and non-dermatomal vitiligo
2.Subjects with 8 -50 years of age.
3.Either gender
4.With any duration of disease, site, extension and distribution of lesions
5.Willingness to give written informed consent form.
1.Subjects with active vitiligo treatment with other drugs/systems
2.Non-cooperative subjects
3.H/o of drug or alcohol abuse, chronic smokers not willing to abstain from smoking during the study period
4.Any clinically significant abnormality identified on physical examination or laboratory tests
5.Subjects having any systemic disease and other skin diseases.
6.Subjects with known allergies
7.Impaired Cardiac, Hepatic and Renal function
8.History of malignancy
9.Concomitant use of any other antioxidants
10.History of hypersensitivity to any of the investigational drugs/herbal medicine.
11.Receiving any other investigational product within 4 weeks
12.Any medical condition, where physician feels participation in the study could be detrimental to subjects well being.
13.Uncontrolled infection
14.Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method